IgG4-related disease

The Lancet

Volumn 385, Issue 9976, 2015, Pages 1460-1471

  Kamisawa, Terumi ^a   Zen, Yoh ^b   Pillai, Shiv ^c   Stone, John H ^c  

^a TOKYO METROPOLITAN KOMAGOME HOSPITAL   (Japan)

^b KOBE UNIVERSITY   (Japan)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; GLUCOCORTICOID; METHOTREXATE; MYCOPHENOLATE MOFETIL; RITUXIMAB; IMMUNOGLOBULIN G;

AORTA DISEASE; AORTITIS; CHOLECYSTITIS; CHRONIC DISEASE; CHRONIC PERIAORTITIS; CLINICAL TRIAL (TOPIC); CORTICOSTEROID THERAPY; EAR NOSE THROAT DISEASE; HISTOPATHOLOGY; HUMAN; HUMORAL IMMUNE DEFICIENCY; IMMUNOGLOBULIN G4 RELATED DISEASE; IMMUNOHISTOCHEMISTRY; IMMUNOTHERAPY; KIDNEY DISEASE; LUNG DISEASE; LYMPHADENOPATHY; MOLECULAR EPIDEMIOLOGY; MUSCULOSKELETAL DISEASE; ORBIT DISEASE; PANCREAS DISEASE; PATHOPHYSIOLOGY; PREVALENCE; PRIORITY JOURNAL; RETROPERITONEAL FIBROSIS; REVIEW; SALIVARY GLAND DISEASE; SCLEROSING CHOLANGITIS; SERODIAGNOSIS; THORACIC AORTA; THYROID DISEASE; FEMALE; FIBROSIS; IMMUNE SYSTEM DISEASES; IMMUNOLOGY; LYMPHOCYTE; MALE; PATHOLOGY; PHLEBITIS; PLASMA CELL;

FEMALE; FIBROSIS; GLUCOCORTICOIDS; HUMANS; IMMUNE SYSTEM DISEASES; IMMUNOGLOBULIN G; LYMPHOCYTES; MALE; PHLEBITIS; PLASMA CELLS;

EID: 84928700021     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(14)60720-0     Document Type: Review

References (106)

1. Mahajan VS, Mattoo H, Deshpande V., Pillai SS, Stone JH. IgG4-related disease. Annu Rev Pathol 2014; 9: 315-47.
2. Umehara H, Okazaki K, Masaki Y., et al, and the Research Program for Intractable Disease by Ministry of Health, Labor and Welfare (MHLW) Japan G4 team. A novel clinical entity, IgG4-related disease (IgG4RD): general concept and details. Mod Rheumatol 2012; 22: 1-14.
3. Stone JH, Khosroshahi A, Deshpande V., et al. Recommendations for the nomenclature of IgG4-related disease and its individual organ system manifestations. Arthritis Rheum 2012; 64: 3061-67.
4. Kawa S, Kawano M. IgG4-related disease: an overview. In: Umehara H, Okazaki K, Stone JH, Kawa S, Kawano M, eds. IgG4-related disease. Berlin: Springer, 2013.
5. Kamisawa T, Egawa N, Nakajima H. Autoimmune pancreatitis is a systemic autoimmune disease. Am J Gastroenterol 2003; 98: 2811-12.
6. Kamisawa T, Funata N, Hayashi Y., et al. A new clinicopathological entity of IgG4-related autoimmune disease. J Gastroenterol 2003; 38: 982-84.
7. Kanno A, Nishimori I, Masamune A., et al, and the Research Committee on Intractable Diseases of Pancreas. Nationwide epidemiological survey of autoimmune pancreatitis in Japan. Pancreas 2012; 41: 835-39.
8. Stone JH, Zen Y, Deshpande V. IgG4-related disease. N Engl J Med 2012; 366: 539-51.
9. Zen Y, Nakanuma Y. IgG4-related disease: a cross-sectional study of 114 cases. Am J Surg Pathol 2010; 34: 1812-19.
10. Ota M, Ito T, Umemura T., et al. Polymorphism in the KCNA3 gene is associated with susceptibility to autoimmune pancreatitis in the Japanese population. Dis Markers 2011; 31: 223-29.
11. Umemura T, Ota M, Hamano H., et al. Association of autoimmune pancreatitis with cytotoxic T-lymphocyte antigen 4 gene polymorphisms in Japanese patients. Am J Gastroenterol 2008; 103: 588-94.
12. Ota M, Katsuyama Y, Hamano H., et al. Two critical genes (HLA-DRB1 and ABCF1)in the HLA region are associated with the susceptibility to autoimmune pancreatitis. Immunogenetics 2007; 59: 45-52.
13. Umemura T, Ota M, Hamano H., Katsuyama Y, Kiyosawa K, Kawa S. Genetic association of Fc receptor-like 3 polymorphisms with autoimmune pancreatitis in Japanese patients. Gut 2006; 55: 1367-68.
14. Deshpande V, Zen Y, Chan J.K., et al. Consensus statement on the pathology of IgG4-related disease. Mod Pathol 2012; 25: 1181-92.
15. Zen Y, Inoue D, Kitao A., et al. IgG4-related lung and pleural disease: a clinicopathologic study of 21 cases. Am J Surg Pathol 2009; 33: 1886-93.
16. Hamano H, Kawa S, Ochi Y., et al. Hydronephrosis associated with retroperitoneal fibrosis and sclerosing pancreatitis. Lancet 2002; 359: 1403-04.
17. Kamisawa T, Funata N, Hayashi Y., et al. Close relationship between autoimmune pancreatitis and multifocal fibrosclerosis. Gut 2003; 52: 683-87.
18. Strehl JD, Hartmann A, Agaimy A. Numerous IgG4-positive plasma cells are ubiquitous in diverse localised non-specific chronic inflammatory conditions and need to be distinguished from IgG4-related systemic disorders. J Clin Pathol 2011; 64: 237-43.
19. Zen Y, Harada K, Sasaki M., et al. IgG4-related sclerosing cholangitis with and without hepatic inflammatory pseudotumor, and sclerosing pancreatitis-associated sclerosing cholangitis: do they belong to a spectrum of sclerosing pancreatitis? Am J Surg Pathol 2004; 28: 1193-203.
20. Aalberse RC, Stapel SO, Schuurman J, Rispens T. Immunoglobulin G4: an odd antibody. Clin Exp Allergy 2009; 39: 469-77.
21. Okazaki K, Uchida K, Ohana M., et al. Autoimmune-related pancreatitis is associated with autoantibodies and a Th1/Th2-type cellular immune response. Gastroenterology 2000; 118: 573-81.
22. Zen Y, Fujii T, Harada K., et al. Th2 and regulatory immune reactions are increased in immunoglobin G4-related sclerosing pancreatitis and cholangitis. Hepatology 2007; 45: 1538-46.
23. Mattoo H, Della-Torre E, Mahajan V.S., Stone JH, Pillai S. Circulating Th2 memory cells in IgG4-related disease are restricted to a defined subset of subjects with atopy. Allergy 2014; 69: 399-402.
24. Della Torre E., Mattoo H, Mahajan V.S., Carruthers M., Pillai S, Stone JH. Prevalence of atopy, eosinophilia, and IgE elevation in IgG4-related disease. Allergy 2014; 69: 269-72.
25. Tsuboi H, Matsuo N, Iizuka M., et al. Analysis of IgG4 class switch-related molecules in IgG4-related disease. Arthritis Res Ther 2012; 14: R171.
26. King C, Tangye SG, Mackay CR T follicular helper (TFH) cells in normal and dysregulated immune responses. Annu Rev Immunol 2008; 26: 741-66.
27. Khosroshahi A, Bloch DB, Deshpande V, Stone JH Rituximab therapy leads to rapid decline of serum IgG4 levels and prompt clinical improvement in IgG4-related systemic disease. Arthritis Rheum 2010; 62: 1755-62.
28. Khosroshahi A, Carruthers MN, Deshpande V, Unizony S., Bloch DB, Stone JH. Rituximab for the treatment of IgG4-related disease: lessons from 10 consecutive patients. Medicine (Baltimore) 2012; 91: 57-66.
29. Ebbo M, Grados A, Guedj E., et al. Usefulness of 2-[18F]-fluoro-2-deoxy-D-glucose-positron emission tomography/computed tomography for staging and evaluation of treatment response in IgG4-related disease: a retrospective multicenter study. Arthritis Care Res (Hoboken) 2014; 66: 86-96.
30. Shimosegawa T, Chari ST, Frulloni L, et a.l., and the International Association of Pancreatology. International consensus diagnostic criteria for autoimmune pancreatitis: guidelines of the International Association of Pancreatology. Pancreas 2011; 40: 352-58.
31. Ohara H, Okazaki K, Tsubouchi H., et al, and the Research Committee of IgG4-related Diseases, and the Research Committee of Intractable Diseases of Liver and Biliary Tract, and the Ministry of Health, Labor and Welfare, Japan, and the Japan Biliary Association. Clinical diagnostic criteria of IgG4-related sclerosing cholangitis 2012. J Hepatobiliary Pancreat Sci 2012; 19: 536-42.
32. Kawano M, Saeki T, Nakashima H., et al. Proposal for diagnostic criteria for IgG4-related kidney disease. Clin Exp Nephrol 2011; 15: 615-26.
33. Masaki Y, Sugai S, Umehara H. IgG4-related diseases including Mikulicz's disease and sclerosing pancreatitis: diagnostic insights. J Rheumatol 2010; 37: 1380-85.
34. Umehara H, Okazaki K, Masaki Y., et al. Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD), 2011. Mod Rheumatol 2012; 22: 21-30.
35. Sah RP, Chari S T. Serologic issues in IgG4-related systemic disease and autoimmune pancreatitis. Curr Opin Rheumatol 2011; 23: 108-13.
36. Tabata T, Kamisawa T, Takuma K., et al. Serum IgG4 concentrations and IgG4-related sclerosing disease. Clin Chim Acta 2009; 408: 25-28.
37. Carruthers MN, Khosroshahi A, Augustin T., Deshpande V, Stone JH. The diagnostic utility of serum IgG4 concentrations in patients with potential IgG4-related disease. Ann Rheum Dis 2014; published online March 20. DOI:10.1136/annrheumdis-2013-204907.
38. Ghazale A, Chari ST, Smyrk T.C., et al. Value of serum IgG4 in the diagnosis of autoimmune pancreatitis and in distinguishing it from pancreatic cancer. Am J Gastroenterol 2007; 102: 1646-53.
39. Sadler R, Chapman RW, Simpson D, et al The diagnostic significance of serum IgG4 levels in patients with autoimmune pancreatitis: a UK study. Eur J Gastroenterol Hepatol 2011; 23: 139-45.
40. Boonstra K, Culver EL, de Buy Wenniger LM, et al. Serum IgG4 and IgG1 for distinguishing IgG4-associated cholangitis from primary sclerosing cholangitis. Hepatology 2014; 59: 1954-63.
41. Wallace ZS, Mattoo H, Carruthers M.N., et al. Plasmablasts as a biomarker for IgG4-related disease, independent of serum IgG4 concentrations. Ann Rheum Dis 2014; published online May 9. DOI:10.1136/annrheumdis-2014-205233.rint.
42. Mattoo H, Mahajan VS, Della Torre E, et al. De novo oligoclonal expansions of circulating plasmablasts in active and relapsing IgG4-related disease. J Allergy Clin Immunol 2014; published online May 6. DOI:10.1016/j.jaci.2014.03.034.
43. Kamisawa T, Shimosegawa T, Okazaki K., et al. Standard steroid treatment for autoimmune pancreatitis. Gut 2009; 58: 1504-07.
44. Khosroshahi A, Cheryk LA, Carruthers M.N., Edwards JA, Bloch DB, Stone JH. Brief Report: spuriously low serum IgG4 concentrations caused by the prozone phenomenon in patients with IgG4-related disease. Arthritis Rheum (Munch) 2014; 66: 213-17.
45. Wallace ZS, Deshpande V, Stone JH Ophthalmic manifestations of IgG4-related disease: single-center experience and literature review. Semin Arthritis Rheum 2013; 43: 806-17.
46. Ohno K, Sato Y, Ohshima K., et al. IgG4-related disease involving the sclera. Mod Rheumatol 2014; 24: 195-98.
47. Wallace ZS, Khosroshahi A, Jakobiec F.A., et al. IgG4-related systemic disease as a cause of "idiopathic" orbital inflammation, including orbital myositis, and trigeminal nerve involvement. Surv Ophthalmol 2012; 57: 26-33.
48. Inoue D, Zen Y, Sato Y., et al. IgG4-related perineural disease. Int J Rheumatol 2012; 29: 212-18.
49. Takahira M, Ozawa Y, Kawano M., et al. Clinical aspects of IgG4-related orbital inflammation in a case series of ocular adnexal lymphoproliferative disorders. Int J Rheumatol 2012; published online April 2. DOI:10.1155/2012/635473.
50. Baer AN, Gourin CG, Westra W.H., Cox DP, Greenspan JS, Daniels TE, and the Sjögren's International Collaborative Alliance. Rare diagnosis of IgG4-related systemic disease by lip biopsy in an international Sjögren syndrome registry. Oral Surg Oral Med Oral Pathol Oral Radiol 2013; 115: e34-39.
51. Hermet M, André M, Kémény JL, et al. Is IgG4-related disease a cause of xerostomia? A cohort study of 60 patients. Int J Rheumatol 2012; published online Oct 16. DOI:10.1155/2012/303506.
52. Geyer JT, Ferry JA, Harris N.L., et al. Chronic sclerosing sialadenitis (Küttner tumor) is an IgG4-associated disease. Am J Surg Pathol 2010; 34: 202-10.
53. Yao Q, Wu G, Hoschar A. IgG4-related Mikulicz's disease is a multiorgan lymphoproliferative disease distinct from Sjögren's syndrome: a Caucasian patient and literature review. Clin Exp Rheumatol 2013; 31: 289-94.
54. Himi T, Takano K, Yamamoto M., Naishiro Y, Takahashi H. A novel concept of Mikulicz's disease as IgG4-related disease. Auris Nasus Larynx 2012; 39: 9-17.
55. Fatemi G, Fang MA IgG4-related pharyngitis-an addition to the nomenclature of IgG4-related disease: comment on the article by Stone et al. Arthritis Rheum 2013; 65: 2217.
56. Hu EK, Parrish C, Wrobel B., Deshpande V, Stone JH. Immunoglobulin G4-related disease presenting as an ethmoid and maxillary mass. Ann Allergy Asthma Immunol 2013; 111: 75-77.
57. Schiffenbauer AI, Gahl WA, Pittaluga S, et al IgG4-related disease presenting as recurrent mastoiditis. Laryngoscope 2012; 122: 681-84.
58. Dahlgren M, Khosroshahi A, Nielsen G.P., Deshpande V., Stone JH. Riedel's thyroiditis and multifocal fibrosclerosis are part of the IgG4-related systemic disease spectrum. Arthritis Care Res (Hoboken) 2010; 62: 1312-18.
59. Deshpande V, Huck A, Ooi E., Stone JH, Faquin WC, Nielsen GP. Fibrosing variant of Hashimoto thyroiditis is an IgG4 related disease. J Clin Pathol 2012; 65: 725-28.
60. Pusztaszeri M, Triponez F, Pache J.C., Bongiovanni M. Riedel's thyroiditis with increased IgG4 plasma cells: evidence for an underlying IgG4-related sclerosing disease? Thyroid 2012; 22: 964-68.
61. Watanabe T, Maruyama M, Ito T., et al. Clinical features of a new disease concept, IgG4-related thyroiditis. Scand J Rheumatol 2013; 42: 325-30.
62. Cheuk W, Chan JK Lymphadenopathy of IgG4-related disease: an underdiagnosed and overdiagnosed entity. Semin Diagn Pathol 2012; 29: 226-34.
63. Kasashima S, Zen Y, Kawashima A., et al. A clinicopathologic study of immunoglobulin G4-related sclerosing disease of the thoracic aorta. J Vasc Surg 2010; 52: 1587-95.
64. Stone JH, Patel VI, Oliveira G.R., Stone JR. Case records of the Massachusetts General Hospital: case 38-2012, a 60-year-old man with abdominal pain and aortic aneurysms. N Engl J Med 2012; 367: 2335-46.
65. Zen Y, Kasashima S, Inoue D. Retroperitoneal and aortic manifestations of immunoglobulin G4-related disease. Semin Diagn Pathol 2012; 29: 212-18.
66. Stone JR. Aortitis, periaortitis, and retroperitoneal fibrosis, as manifestations of IgG4-related systemic disease. Curr Opin Rheumatol 2011; 23: 88-94.
67. Inoue D, Zen Y, Abo H., et al. Immunoglobulin G4-related periaortitis and periarteritis: CT findings in 17 patients. Radiology 2011; 261: 625-33.
68. Inokuchi G, Hayakawa M, Kishimoto T., Makino Y, Iwase H. A suspected case of coronary periarteritis due to IgG4-related disease as a cause of ischemic heart disease. Forensic Sci Med Pathol 2014; 10: 103-08.
69. Khosroshahi A, Carruthers MN, Stone J.H., et al. Rethinking Ormond's disease: "idiopathic" retroperitoneal fibrosis in the era of IgG4-related disease. Medicine (Baltimore) 2013; 92: 82-91.
70. Zen Y, Onodera M, Inoue D., et al. Retroperitoneal fibrosis: a clinicopathologic study with respect to immunoglobulin G4. Am J Surg Pathol 2009; 33: 1833-39.
71. Inoue D, Zen Y, Abo H., et al. Immunoglobulin G4-related lung disease: CT findings with pathologic correlations. Radiology 2009; 251: 260-70.
72. Saeki T, Nishi S, Imai N., et al. Clinicopathological characteristics of patients with IgG4-related tubulointerstitial nephritis. Kidney Int 2010; 78: 1016-23.
73. Saeki T, Kawano M, Mizushima I., et al. The clinical course of patients with IgG4-related kidney disease. Kidney Int 2013; 84: 826-33.
74. Alexander MP, Larsen CP, Gibson I.W., et al. Membranous glomerulonephritis is a manifestation of IgG4-related disease. Kidney Int 2013; 83: 455-62.
75. Beck LH J.r., Bonegio RG, Lambeau G, et al M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy. N Engl J Med 2009; 361: 11-21.
76. Khosroshahi A, Ayalon R, Beck LH Jr, Salant DJ, Bloch DB, Stone JH. IgG4-related disease is not associated with antibody to the phospholipase A2 receptor. Int J Rheumatol 2012; published online May 10. DOI:10.1155/2012/139409.
77. Hamano H, Kawa S, Horiuchi A., et al. High serum IgG4 concentrations in patients with sclerosing pancreatitis. N Engl J Med 2001; 344: 732-38.
78. Sah RP, Chari ST, Pannala R, et al Differences in clinical profile and relapse rate of type 1 versus Type 2 autoimmune pancreatitis. Gastroenterology 2010; 139: 140-48, quiz e12-13.
79. Hart PA, Kamisawa T, Brugge W.R., et al. Long-term outcomes of autoimmune pancreatitis: a multicentre, international analysis. Gut 2013; 62: 1771-76.
80. Kamisawa T, Chari ST, Lerch M.M., Kim MH, Gress TM, Shimosegawa T. Recent advances in autoimmune pancreatitis: type 1 and Type 2. Gut 2013; 62: 1373-80.
81. Kamisawa T, Takuma K, Egawa N., Tsuruta K, Sasaki T. Autoimmune pancreatitis and IgG4-related sclerosing disease. Nat Rev Gastroenterol Hepatol 2010; 7: 401-09.
82. Sugumar A, Levy MJ, Kamisawa T, et al Endoscopic retrograde pancreatography criteria to diagnose autoimmune pancreatitis: an international multicentre study. Gut 2011; 60: 666-70.
83. Ozaki Y, Oguchi K, Hamano H., et al. Differentiation of autoimmune pancreatitis from suspected pancreatic cancer by fluorine-18 fluorodeoxyglucose positron emission tomography. J Gastroenterol 2008; 43: 144-51.
84. Pezzilli R, Vecchiarelli S, Di Marco MC, et al. Pancreatic ductal adenocarcinoma associated with autoimmune pancreatitis. Case Rep Gastroenterol 2011; 5: 378-85.
85. Gupta R, Khosroshahi A, Shinagare S., et al. Does autoimmune pancreatitis increase the risk of pancreatic carcinoma?: a retrospective analysis of pancreatic resections. Pancreas 2013; 42: 506-10.
86. Maruyama M, Arakura N, Ozaki Y., et al. Type 1 autoimmune pancreatitis can transform into chronic pancreatitis: a long-term follow-up study of 73 Japanese patients. Int J Rheumatol 2013; published online May 16. DOI:10.1155/2013/272595.
87. Hirano K, Tada M, Isayama H., et al. Endoscopic evaluation of factors contributing to intrapancreatic biliary stricture in autoimmune pancreatitis. Gastrointest Endosc 2010; 71: 85-90.
88. Mendes FD, Jorgensen R, Keach J., et al. Elevated serum IgG4 concentration in patients with primary sclerosing cholangitis. Am J Gastroenterol 2006; 101: 2070-75.
89. Oseini AM, Chaiteerakij R, Shire A.M., et al. Utility of serum immunoglobulin G4 in distinguishing immunoglobulin G4-associated cholangitis from cholangiocarcinoma. Hepatology 2011; 54: 940-48.
90. Kalaitzakis E, Levy M, Kamisawa T., et al. Endoscopic retrograde cholangiography does not reliably distinguish IgG4-associated cholangitis from primary sclerosing cholangitis or cholangiocarcinoma. Clin Gastroenterol Hepatol 2011; 9: 800-03, e2.
91. Itoi T, Kamisawa T, Igarashi Y., et al. The role of peroral video cholangioscopy in patients with IgG4-related sclerosing cholangitis. J Gastroenterol 2013; 48: 504-14.
92. Nakazawa T, Ando T, Hayashi K., Naitoh I, Ohara H, Joh T. Diagnostic procedures for IgG4-related sclerosing cholangitis. J Hepatobiliary Pancreat Sci 2011; 18: 127-36.
93. Wallace ZS, Carruthers MN, Khosroshahi A, et al IgG4-related disease and hypertrophic pachymeningitis. Medicine (Baltimore) 2013; 92: 206-16.
94. Leporati P, Landek-Salgado MA, Lupi I., Chiovato L, Caturegli P. IgG4-related hypophysitis: a new addition to the hypophysitis spectrum. J Clin Endocrinol Metab 2011; 96: 1971-80.
95. Peikert T, Shrestha B, Aubry M.C., et al. Histopathologic overlap between fibrosing mediastinitis and IgG4-related disease. Int J Rheumatol 2012; published online May 10. DOI:10.1155/2012/207056.
96. Salvarani C, Valli R, Boiardi L., Pipitone N, Nicoli F, Muratore F. IgG4-associated sclerosing mesenteritis. Clin Exp Rheumatol 2011; 29 (suppl 64): S79-80.
97. Ikeda T, Oka M, Shimizu H., et al. IgG4-related skin manifestations in patients with IgG4-related disease. Eur J Dermatol 2013; 23: 241-45.
98. Hart PA, Smyrk TC, Chari ST IgG4-related prostatitis: a rare cause of steroid-responsive obstructive urinary symptoms. Int J Urol 2013; 20: 132-34.
99. Kamisawa T, Okazaki K, Kawa S., Shimosegawa T, Tanaka M, and the Research Committee for Intractable Pancreatic Disease and Japan Pancreas Society. Japanese consensus guidelines for management of autoimmune pancreatitis: III. Treatment and prognosis of AIP. J Gastroenterol 2010; 45: 471-77.
100. Masaki Y, for the All-Japan Team for the Prospective Treatment Study of IgG4-RD. A trial of corticosteroids for IgG4-related disease. Second International Symposium on IgG4-related Disease & Associated Conditions, Honolulu, HA, USA, February 16-19, 2014.
101. Kamisawa T, Egawa N, Inokuma S., et al. Pancreatic endocrine and exocrine function and salivary gland function in autoimmune pancreatitis before and after steroid therapy. Pancreas 2003; 27: 235-38.
102. Ito T, Kawabe K, Arita Y., et al. Evaluation of pancreatic endocrine and exocrine function in patients with autoimmune pancreatitis. Pancreas 2007; 34: 254-59.
103. Ko SB, Mizuno N, Yatabe Y., et al. Corticosteroids correct aberrant CFTR localization in the duct and regenerate acinar cells in autoimmune pancreatitis. Gastroenterology 2010; 138: 1988-96.
104. Shimizu Y, Yamamoto M, Naishiro Y., et al. Necessity of early intervention for IgG4-related disease-delayed treatment induces fibrosis progression. Rheumatology (Oxford) 2013; 52: 679-83.
105. Hart PA, Topazian MD, Witzig T.E., et al. Treatment of relapsing autoimmune pancreatitis with immunomodulators and rituximab: the Mayo Clinic experience. Gut 2013; 62: 1607-15.
106. Carruthers MN, Khosroshahi A, Topazian M., et al. Rituximab for IgG4-related disease: a prospective treatment trial. Arthritis Rheum 2013; 10: 2649.